Asymptomatic Left Ventricular Dysfunction: Is There a Role for Screening in General Population?

Salvatore La Carrubba1, Roberta Manganaro2, Concetta Zito2

  • 1Villa Sofia Hospital, Palermo, Italy.

Heart Failure Clinics
|March 6, 2021
PubMed

Insights

Early detection of asymptomatic left ventricular dysfunction is crucial for preventing heart failure (HF). Echocardiography is ideal for screening, and new technologies may enhance early detection of cardiac dysfunction.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Stage A and B heart failure (HF) involve asymptomatic individuals, with Stage B characterized by structural cardiac disorders.
  • Asymptomatic left ventricular (LV) dysfunction signifies an early, preclinical stage of HF.
  • Early recognition of LV dysfunction is vital to prevent progression to overt HF.

Purpose of the Study:

  • To highlight the role of echocardiography in screening for early-stage heart failure.
  • To emphasize the importance of detecting asymptomatic left ventricular dysfunction.
  • To explore the potential of novel echocardiographic technologies in identifying early LV dysfunction.

Main Methods:

  • Traditional echocardiography assesses LV systolic and diastolic function and cardiac remodeling.
  • Echocardiography is presented as a feasible, low-cost, and accessible screening tool for the general population.
  • The study discusses the integration of new imaging technologies for enhanced detection.

Main Results:

  • Echocardiography is pivotal for assessing cardiac structure and function.
  • Traditional echocardiographic assessments are standard for evaluating LV function and remodeling.
  • Emerging echocardiographic technologies offer potential for improved detection of early LV dysfunction.

Conclusions:

  • Echocardiography is the preferred imaging technique for screening asymptomatic individuals for early heart failure.
  • Identifying asymptomatic LV dysfunction is key to preventing overt heart failure.
  • Advancements in echocardiography promise to improve the early diagnosis of cardiac dysfunction.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
188
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
82
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
159
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
144
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
212
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
330